| scholarly article | Q13442814 |
| P50 | author | Bin Wu | Q51132574 |
| P2093 | author name string | Yu Lu | |
| Jie Jiang | |||
| Xiaoli Huang | |||
| Xiaoliang Chen | |||
| Huiling Liu | |||
| Minyi Xu | |||
| Siwei Tan | |||
| Xiaojie Peng | |||
| P2860 | cites work | Physiology and pathophysiology of cyclooxygenase-2 and prostaglandin E2 in the kidney | Q26771378 |
| E-type prostanoid receptor 4 (EP4) in disease and therapy | Q26851156 | ||
| Visualization of arrestin recruitment by a G-protein-coupled receptor | Q28244290 | ||
| GPCR-G Protein-β-Arrestin Super-Complex Mediates Sustained G Protein Signaling | Q28277702 | ||
| The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors | Q28552564 | ||
| The Concise Guide to PHARMACOLOGY 2015/16: Enzymes | Q28552567 | ||
| The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands | Q28603128 | ||
| The Concise Guide to PHARMACOLOGY 2015/16: Overview | Q30488640 | ||
| The Concise Guide to PHARMACOLOGY 2015/16: Catalytic receptors | Q30488655 | ||
| Prostaglandin E2 promotes lung cancer cell migration via EP4-betaArrestin1-c-Src signalsome. | Q33794119 | ||
| Animal research: reporting in vivo experiments: the ARRIVE guidelines | Q34116755 | ||
| The Prostaglandin E2 Receptor, EP2, Stimulates Keratinocyte Proliferation in Mouse Skin by G Protein-dependent and β-Arrestin1-dependent Signaling Pathways | Q34400793 | ||
| EGFR/Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer | Q34421001 | ||
| Gastric lesions in portal hypertension: inflammatory gastritis or congestive gastropathy? | Q34527552 | ||
| Emerging paradigms of β-arrestin-dependent seven transmembrane receptor signaling | Q35201347 | ||
| Prostaglandin E2 Inhibits NLRP3 Inflammasome Activation through EP4 Receptor and Intracellular Cyclic AMP in Human Macrophages | Q35612957 | ||
| β-Arrestin drives MAP kinase signalling from clathrin-coated structures after GPCR dissociation. | Q36619784 | ||
| The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment | Q37366259 | ||
| PUMA mediates ER stress-induced apoptosis in portal hypertensive gastropathy. | Q37680278 | ||
| Portal hypertensive gastropathy: a review | Q37764023 | ||
| Multifaceted roles of PGE2 in inflammation and cancer | Q38045226 | ||
| The prostanoid EP4 receptor and its signaling pathway. | Q38115283 | ||
| Review article: the management of portal hypertensive gastropathy and gastric antral vascular ectasia in cirrhosis. | Q38217017 | ||
| Portal hypertensive gastropathy: A systematic review of the pathophysiology, clinical presentation, natural history and therapy | Q38726165 | ||
| Insulin-Like Growth Factor-1 Contributes to Mucosal Repair by β-Arrestin2-Mediated Extracellular Signal-Related Kinase Signaling in Experimental Colitis. | Q38835925 | ||
| β-Arrestin1 enhances hepatocellular carcinogenesis through inflammation-mediated Akt signalling. | Q38863857 | ||
| The Portal Hypertensive Gastropathy: A Case and Review of Literature | Q38922604 | ||
| c-Src and Pyk2 protein tyrosine kinases play protective roles in early HIV-1 infection of CD4+ T-cell lines | Q39035379 | ||
| Prostaglandin E2 downregulates TNF-alpha-induced production of matrix metalloproteinase-1 in HCS-2/8 chondrocytes by inhibiting Raf-1/MEK/ERK cascade through EP4 prostanoid receptor activation | Q40221802 | ||
| Identification of a Ser/Thr cluster in the C-terminal domain of the human prostaglandin receptor EP4 that is essential for agonist-induced beta-arrestin1 recruitment but differs from the apparent principal phosphorylation site | Q40601716 | ||
| Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP. | Q42332476 | ||
| Experimental design and analysis and their reporting: new guidance for publication in BJP. | Q42356330 | ||
| Inhibition of Src kinase blocks high glucose-induced EGFR transactivation and collagen synthesis in mesangial cells and prevents diabetic nephropathy in mice. | Q42936581 | ||
| Endogenous prostaglandin E2 accelerates healing of indomethacin-induced small intestinal lesions through upregulation of vascular endothelial growth factor expression by activation of EP4 receptors | Q43002209 | ||
| Downregulation of cyclooxygenase-1 is involved in gastric mucosal apoptosis via death signaling in portal hypertensive rats | Q43294876 | ||
| Redox regulation of anoikis resistance of metastatic prostate cancer cells: key role for Src and EGFR-mediated pro-survival signals | Q46045421 | ||
| β-Arrestin-1 protects against endoplasmic reticulum stress/p53-upregulated modulator of apoptosis-mediated apoptosis via repressing p-p65/inducible nitric oxide synthase in portal hypertensive gastropathy | Q85485775 | ||
| Cyclooxygenase-2-derived prostaglandin E2 promotes human cholangiocarcinoma cell growth and invasion through EP1 receptor-mediated activation of the epidermal growth factor receptor and Akt | Q85622475 | ||
| Portal hypertensive gastropathy and gastric antral vascular ectasia | Q86172611 | ||
| Arrestin interaction with E3 ubiquitin ligases and deubiquitinases: functional and therapeutic implications | Q86870983 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 848-866 | |
| P577 | publication date | 2017-03-25 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | PGE2 /EP4 receptor attenuated mucosal injury via β-arrestin1/Src/EGFR-mediated proliferation in portal hypertensive gastropathy. | |
| P478 | volume | 174 |
Search more.